The increasing prevalence of cancer among women across the
globe is one of the factors acting as a driver for the cervical dysplasia
market. In a report published by the WHO in 2018, more than 0.57 million cases
of cervical dysplasia were reported worldwide. Initiatives by key players to
develop better colposcope devices may fuel the growth of the cervical dysplasia
market during the forecast period. Colposcope devices are recognized as the
main diagnostic tools that help diagnose cervical dysplasia.
Explore More Insights@ https://www.alliedmarketresearch.com/request-toc-and-sample/12707
In March 2018, Fast Trach Diagnostics' sexually transmitted
infection portfolio was expanded to include human papillomavirus (HPV) tests.
These new tests include real-time PCR kits that help detect HPV18, HPV16, HPV12
and other subtypes of human papillomavirus.
The increase in the number of cervical dysplasia awareness
programs for early diagnosis of this disease acts as a major driver of the
market. However, low number of cervical screening in developing countries and
lack of awareness about cervical dysplasia hampers the growth of the cervical
dysplasia market. The number of government-funded screening programs for
cervical dysplasia has increased over the years and the global market has
grown.
Since cervical dysplasia is one of the most common
HPV-related cancers in women, the number of screenings for lesions caused by
this disease has increased. Hence, this factor has fueled the growth of the
cervical dysplasia market.
Covid-19 Impact Analysis:
Due to Covid-19, the supply chain of raw materials required
to manufacture medicinal products for cervical dysplasia has been disrupted in
many countries. In addition, growth in the pharmaceutical market has slowed, as
drug manufacturers have reduced their production due to the pandemic. This, in
turn, is expected to have a significant impact on the cervical dysplasia
market.
0 Comments